Gabrielle E. Foxa

An osteocalcin-deficient mouse strain without endocrine abnormalities

Cassandra R Diegel, Jennifer C W Hu, Gabrielle E Foxa, 2019, bioRxiv.

Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy

Cassandra R Diegel, Gabrielle E Foxa, B. Williams, 2018, Bone Research.

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor

Gabrielle E Foxa, B. Williams, P. Grohar, 2020, EMBO molecular medicine.

Direct therapeutic targeting of SWI/SNF induces epigenetic reprogramming and durable tumor regression in rhabdoid tumor

Gabrielle E Foxa, B. Williams, P. Grohar, 2019, bioRxiv.

LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL‐Stimulated NF‐κB and p38 Pathways During Osteoclastogenesis

Gabrielle E Foxa, J. Li, B. Williams, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Frizzled‐4 is required for normal bone acquisition despite compensation by Frizzled‐8

Gabrielle E Foxa, B. Williams, R. Tomlinson, 2020, Journal of cellular physiology.

Low-density Lipoprotein Receptor-related Protein 5 (LRP5)-deficient Rats Have Reduced Bone Mass and Abnormal Development of the Retinal Vasculature

Cassandra R Diegel, Gabrielle E Foxa, B. Williams, 2020, bioRxiv.

Independent validation of experimental results requires timely and unrestricted access to animal models and reagents

Cassandra R Diegel, Steven Hann, Ugur M Ayturk, 2020, PLoS genetics.

Low-density Lipoprotein Receptor-related Protein 5 (LRP5)-deficient Rats Have Reduced Bone Mass and Abnormal Development of the Retinal Vasculature

Cassandra R Diegel, Gabrielle E Foxa, B. Williams, 2020, bioRxiv.

Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5

Cassandra R Diegel, Jun Liu, Jennifer L. Harris, 2023, Bone research.